Tuesday, November 10, 2020 Daily Archives

CMC Testing Support for Gene and Cell Therapy

Eurofins BioPharma Product Testing supports the development of ATMPs both for traditional use as well as for use in personalized medicine. We provide comprehensive GMP-compliant CMC testing support to ensure the identity, potency, purity, and safety of starting materials, intermediate products, vectors, and final drug products as well as support for manufacturing process development and validation. Testing Capabilities include Raw Materials, Cell Banks, Virus Banks, Plasmid Vector, Harvest (Lot Release Testing), and Bulk & Finished Products. We support gene therapies,…

Repligen up on COVID-19 and gene therapy related demand

COVID-19 related demand helped Repligen in Q3 with the emerging gene therapy sector also providing a revenue boost. The processing technology firm’s revenue reached $94.1 million for the three months ended September 30, up 35% year-on-year. Gross profits also increased, climbing 40% to $54.5 million. Repligen attributed the gains to increased demand for its technologies from companies working on SARS-CoV-2 vaccines or related therapeutics. CEO Tony Hunt told analysts “We estimate that COVID programs accounted for approximately 55% of our…